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A 32-year-old man developed systemic right ventricular (RV) heart failure after ventricular
septal defect (VSD) closure and tricuspid valve replacement for corrected transposition of the
great arteries with VSD and Ebstein anomaly. He subsequently experienced RV failure with
wide QRS and atrial ﬁbrillation (AF). Because corrective surgery for this condition seemed
over risky, we decided to perform cardiac resynchronization therapy with implantation of an
implantable cardioverter deﬁbrillator (CRT-D). After CRT-D device implantation, the patient
showed improved performance status in terms of New York Heart Association functional
class, B-type brain natriuretic peptide levels, RV ejection fraction and cardiac electrical
rhythm. CRT-D implantation is a useful approach for systemic RV failure with wide QRS
duration showing right bundle branch block and AF.
(J Arrhythmia 2010; 26: 267–271)
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Introduction
Cardiac resynchronization therapy (CRT) is ef-
fective in selected patients with ischemic and dilated
cardiomyopathy and symptomatic heart failure de-
spite optimal medical therapy. However, indications
for CRT have not been established in patients with
adult congenital heart disease (ACHD), due to the
heterogeneity of anatomy and physiology. CRT may
have potential beneﬁts for a large number of ACHD
patients with systemic right ventricular (RV) failure.
Case
A 32-year-old man was born with corrected trans-
position of the great arteries (CTGA), ventricular
septal defect (VSD) and Ebstein anomaly. At 4 years
of age, he underwent VSD closure and tricuspid valve
replacement (TVR) (Bjo¨rk-Shiley prosthetic valve).
At 8 years of age, VSD closure for residual leak and
re-TVR (SJM prosthetic valve) were performed. At
16 years of age, RV reconstruction for RV aneurysm
and a third TVR for size mismatch following body
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Case Report
growth were performed. At 30 years of age, severe
systemic RV failure gradually appeared and resting
electrocardiography (ECG) showed atrial ﬁbrillation
(AF) and right bundle branch block (RBBB) with
wide QRS (120ms) (Figure 1). Despite administration
of optimal pharmacotherapies such as carperitide,
furosemide, enalaplil, digoxine and carvedilol, RV
failure persisted and orthopnea with lung congestion
appeared (Figure 2).
Before inserting a systemic ventricular lead, we
had to identify the coronary vein anatomy, partic-
ularly the anatomical right coronary vein for systemic
ventricular lead access in CTGA. Coronary angiog-
raphy and retrograde occlusive angiography from the
coronary sinus were useful, revealing the coronary
sinus draining into the right atrium and coming
back from the RV (Figure 3). We could not observe
obvious dyssynchrony on echocardiography because
of muscle overgrowth in the right ventricle. Tempo-
rary bi-ventricular pacing with electrophysiological
study catheters was therefore used to clarify the
feasibility of CRT by monitoring continuous cardiac
output before implantation of CRT-D. CRT was
conﬁrmed to improve hemodynamics despite cardiac
rhythm constantly showing AF (Figures 3, 4).
Under general anesthesia, an RV lead, shock lead
and right atrial lead were inserted using a trans-
venous approach from the left subclavian vein.
Following CRT-D implantation, implantable cardi-
overter deﬁbrillator testing showed improvement in
electrical heart rhythm from AF to sinus rhythm.
CRT increased RV ejection fraction (EF) from
20.9% to 29.9%, improved clinical status from New
York Heart Association (NYHA) from class IV to
class II, and decreased levels of B-type brain
natriuretic peptide (BNP) from 847 pg/ml to
295 pg/ml by 2 weeks after CRT-D implantation.
As of 2 years after CRT-D implantation, the
patient has shown improved cardiac condition with
maintenance of NYHA class I-II and sinus rhythm
using pharmacotherapies such as enalaplil, digoxine,
carvedilol and furosemide.
Discussion
CRT is eﬀective in selected patients with ischemic
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Figure 1
Left: Electrocardiography before CRT showing RBBB (QRS, 120ms) atrial ﬁbrillation. Right: Electrocardiography post CRT-D device
implantation showing sinus rhythm recovery.
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or dilated cardiomyopathy or symptomatic heart
failure despite optimal pharmacotherapy.1–3) In
ACHD, cardiac dysfunction is a major cause of
morbidity and mortality. Janousek et al.4) reported
that CRT is equally or more eﬀective in younger
patients than in adults with idiopathic or ischemic
dilated cardiomyopathy. In addition, 13 (37%) of 35
patients were removed from the transplantation list
after CRT. However, issues speciﬁc to ACHD limit
the applicability of these results and the heteroge-
Figure 2
Left: Chest radiography before CRT, showing lung congestion. Right: Radiography after dual-chamber CRT-D device implantation (RA
lead, LV shock lead and RV lead), showing improved lung congestion and RV lead inserted via a lateral vein.
Figure 3
Left: Coronary angiography before CRT implantation. Right: Coronary vein angiography with balloon occlusion, clearly showing
coronary vein anatomy.
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neous anatomy and physiology prevent large-scale
randomized clinical trials of CRT.
Janousek et al.5) ﬁrst reported the use of CRT
for systemic RV failure in patients with CTGA.
Since then, CRT has proven to be useful in systemic
RV failure. Diller et al.6) reported that 4 to 9% of
unselected patients with systemic RV failure appear
to be potential candidates for CRT. Dubin et al.7)
reported that CRT may oﬀer beneﬁts to pediatric and
congenital heart disease patients who diﬀer substan-
tially from the adult populations in whom this
therapy has typically been evaluated.
The current results are of clinical importance for
patients with systemic RV failure who frequently
develop ventricular dysfunction, require convention-
al pacemaker therapy, or display objective exercise
limitations and electrical dyssynchrony. The propor-
tion of unselected patients with systemic RV who
potentially stand to beneﬁt from this emerging
technology remains unclear. We also consider CRT
as a value option in patients with severe systemic RV
failure and electrical dyssynchrony QRS with a
duration of 120ms or at least with indications for a
pacemaker.
We considered that corrective surgery (such as a
double-switch operation) for this patient would be
too risky, so we treated the patient with CRT-D
because he showed cardiac dysfunction (RBBB),
frequent premature ventricular contraction and arte-
rial ﬁbrillation. In this patient, CRT-D improved
NYHA clinical status, cardiac rhythm, RV ejection
fraction, and BNP levels. Although AF inﬂuenced
RV dysfunction, recovery of regular rhythm was the
most important factor in this improvement, as we
demonstrated that hemodynamics were improved by
temporary bi-ventricular pacing before implantation
of the CRT-D device.
Cecchin et al. reported 60 consecutive patients
who underwent CRT, including 9 patients with
systemic RV failure. In that report, CRT was
associated with improvements in the majority of
children and patients with congenital heart disease.
In patients with RV failure, despite signiﬁcant acute
response in some patients, long-term clinical or
functional improvements are typically limited with
CRT.8) Careful long-term follow-up of the present
patient is thus required.
We reported the case of a patient with CTGA
showing AF with systemic RV failure after conven-
tional repair. This patient was successfully treated
using CRT-D, which improved systemic RV func-
tion and may be an interesting therapeutic option in
patients with systemic RV dysfunction with RBBB
and AF.
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Figure 4
Cardiac index improved immediately after starting temporary CRT. During this examination, cardiac rhythm
showed AF.
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